- Home
- CISO vs SONN Comparison
CISO vs SONN Comparison
Compare CISO & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- SONN
- Stock Information
- Founded
- CISO 2015
- SONN N/A
- Country
- CISO United States
- SONN United States
- Employees
- CISO N/A
- SONN N/A
- Industry
- CISO Computer Software: Prepackaged Software
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- SONN Health Care
- Exchange
- CISO Nasdaq
- SONN Nasdaq
- Market Cap
- CISO 31.4M
- SONN 32.4M
- IPO Year
- CISO N/A
- SONN N/A
- Fundamental
- Price
- CISO $0.53
- SONN $4.52
- Analyst Decision
- CISO
- SONN Strong Buy
- Analyst Count
- CISO 0
- SONN 1
- Target Price
- CISO N/A
- SONN $20.00
- AVG Volume (30 Days)
- CISO 597.6K
- SONN 776.4K
- Earning Date
- CISO 11-13-2025
- SONN 12-16-2025
- Dividend Yield
- CISO N/A
- SONN N/A
- EPS Growth
- CISO N/A
- SONN N/A
- EPS
- CISO N/A
- SONN N/A
- Revenue
- CISO $27,743,266.00
- SONN $1,000,000.00
- Revenue This Year
- CISO N/A
- SONN $5,376.22
- Revenue Next Year
- CISO N/A
- SONN N/A
- P/E Ratio
- CISO N/A
- SONN N/A
- Revenue Growth
- CISO N/A
- SONN 1689.52
- 52 Week Low
- CISO $0.30
- SONN $1.08
- 52 Week High
- CISO $3.84
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- CISO 23.17
- SONN 47.92
- Support Level
- CISO $0.54
- SONN $4.05
- Resistance Level
- CISO $1.04
- SONN $5.14
- Average True Range (ATR)
- CISO 0.09
- SONN 0.94
- MACD
- CISO -0.05
- SONN -0.02
- Stochastic Oscillator
- CISO 1.47
- SONN 48.41
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.